Agilent Technologies, BioTrove to Streamline Drug Discovery Using High-Throughput Mass Spectrometry
News Nov 03, 2008
Agilent Technologies Inc. and BioTrove have announced that they have signed a non-exclusive value-added reseller agreement to enable BioTrove to provide an end-to-end solution for mass spectrometry-based drug discovery. This solution will combine technology leader BioTrove’s RapidFire Mass Spectrometry sample preparation system with Agilent’s mass spectrometers.
The reseller agreement expands on an established strategic relationship between Agilent and BioTrove, furthering both companies’ ability to enhance customer workflows.
BioTrove will provide an integrated solution for drug discovery using mass spectrometry analysis, affording customers access to a single system. BioTrove’s RapidFire system; comprised of microfluidic handling for sample preparation and advanced software; combined with Agilent’s Triple Quadrupole and Time-of-Flight mass spectrometry instruments create a high-throughput advanced workflow solution.
The agreement includes Agilent atmospheric pressure ionization sources with the mass spectrometers, which generate quantitative and qualitative results via sensitive and selective mass analysis, based on the molecular composition of the target compounds.
RapidFire mass spectrometry decreases the bottleneck that occurs during high-throughput screening of candidate drug compounds by enabling automated sample preparation, at a rate of approximately six to eight seconds per sample, followed by seamless integration with the mass spectrometer.
The Friedrich Schiller University Jena Partners with ACD/Labs to Advance its Analytical Data Management StrategyNews
Implementation of ACD/Spectrus as an analytical data management system helps researchers and students streamline NMR and MS data processing, interpretation, collaboration, and training.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018